Journal of the American Academy of Child & Adolescent Psychiatry
SPECIAL ARTICLEEvidence-Based Treatments in Child and Adolescent Psychiatry: An Inventory
Section snippets
ISSUES RELATING TO EVIDENCE
There are several issues and challenges in the development and adoption of evidence-based medicine as the standard of care for child psychiatry.
METHOD
Given the broad nature of the task, we narrowed the search to published reviews, supplemented with more recent studies. The American Academy of Child and Adolescent Psychiatry (AACAP)'s Practice Parameters, the Journal's 10-Year Reviews, a special section on pediatric psychopharmacology edited by Vitiello et al. (1999) in this Journal, two series of reviews on empirically supported treatments published in 1998 and 2001 in the Journal of Clinical Child Psychology, and a review by Fonagy (2000)
PHARMACOLOGY
TABLE 1, TABLE 2, TABLE 3, TABLE 4, TABLE 5 outline the current research support with regard to controlled clinical trials. We will outline the content briefly and by medication class rather than by diagnosis.
PSYCHOSOCIAL INTERVENTIONS
Psychotherapy remains a mainstay of psychiatric treatment. Unfortunately, the existing evidence suggests that the widely used traditional psychotherapies are not effective in youth (Weiss et al., 1999, Weiss et al., 2000; Weisz and Jensen, 2001). Conversely, although research-based psychotherapeutic interventions have documented effectiveness, they are generally not used in clinical practice.
Four meta-analytic studies of psychotherapy research (Casey and Berman, 1985; Kazdin et al., 1990; Weisz
DISCUSSION
Fortunately, there are an increasing number of available research-supported treatments for treating mental health problems in youth. However, most of child psychiatry practice is not evidence-based, in part because patient populations are much more complicated and diverse than research samples, and in part because clinicians are not always trained in, or willing to use, evidence-based modalities. This is a major public health issue, since approximately 20% of children and adolescents suffer
REFERENCES (188)
- et al.
Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance
J Am Acad Child Adolesc Psychiatry
(1991) - et al.
Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder
J Am Acad Child Adolesc Psychiatry
(1995) - et al.
Comparative studies of pharmacotherapy for school refusal
J Am Acad Child Adolesc Psychiatry
(1990) - et al.
A double-blind placebo controlled study of desipramine in the treatment ADD, II. serum drug levels and cardiovascular findings
J Am Acad Child Adolesc Psychiatry
(1989) - et al.
Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study
J Am Acad Child Adolesc Psychiatry
(1994) - et al.
Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial
J Am Acad Child Adolesc Psychiatry
(2003) - et al.
Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study
J Am Acad Child Adolesc Psychiatry
(1995) - et al.
A comparison of haloperidol and behavior therapy and their interaction in autistic children
J Am Acad Child Psychiatry
(1978) - et al.
Naltrexone in autistic children: behavioral symptoms and attentional learning
J Am Acad Child Adolesc Psychiatry
(1993) - et al.
Group cognitive-behavioral treatment for depressed adolescent offspring of depressed parents in a health maintenance organization
J Am Acad Child Adolesc Psychiatry
(2002)
Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions
J Am Acad Child Adolesc Psychiatry
A treatment study for sexually abused preschool children: outcome during a one-year follow-up
J Am Acad Child Adolesc Psychiatry
Bupropion hydrochloride in attention deficit disorder with hyperactivity
J Am Acad Child Adolesc Psychiatry
Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study
J Am Acad Child Adolesc Psychiatry
Two-year follow-up study of cognitive behavioral therapy for sexually abused children suffering post-traumatic stress symptoms
Child Abuse Neg
A double, randomized, placebo-controlled study of quetiapine adjunctive treatment for adolescent mania
J Am Acad Child Adolesc Psychiatry
Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder—a multicenter trial
J Am Acad Child Adolesc Psychiatry
Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial
J Am Acad Child Adolesc Psychiatry
Nontricyclic antidepressants: current trends in children and adolescents
J Am Acad Child Adolesc Psychiatry
A double-blind pilot study of risperidone in the treatment of conduct disorder
J Am Acad Child Adolesc Psychiatry
Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome
J Am Acad Child Adolesc Psychiatry
Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children
J Am Acad Child Adolesc Psychiatry
Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency
J Am Acad Child Adolesc Psychiatry
Child and adolescent bipolar disorder: a review of the past 10 years
J Am Acad Child Adolesc Psychiatry
Critical review of tricyclic antidepressant use in children and adolescents
J Am Acad Child Adolesc Psychiatry
Clonazepam in childhood anxiety disorders
J Am Acad Child Adolesc Psychiatry
Stimulant medications
J Am Acad Child Adolesc Psychiatry
Four-year follow up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders
J Am Acad Child Adolesc Psychiatry
One-year follow-up of multisystemic therapy as an alternative to the hospitalization of youths in psychiatric crisis
Am Acad Child Adolesc Psychiatry
Home-based multisystemic therapy as an alternative to the hospitalization of youths in psychiatric crisis: clinical outcomes
J Am Acad Child Adolesc Psychiatry
Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial
J Am Acad Child Psychiatry
Prevention of depressive symptoms in school children
Behav Res Ther
Treatments for aggressive and antisocial children
Child Adolesc Psychiatr Clin North Am
Effects of parent management training and problem-solving skills training combined in the treatment of antisocial child behavior
J Am Acad Child Adolesc Psychiatry
Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial
J Am Acad Child Adolesc Psychiatry
Treating sexually abused children with posttraumatic stress symptoms: a randomized clinical trial
J Am Acad Child Adolesc Psychiatry
Short-term behavioral intervention with delinquent families: impact on family process and recidivism
J Abnorm Psychol
Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence
Am J Psychiatry
Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and reinforcement contingencies
Am J Ment Retard
The effects of methylphenidate and haloperidol on the heart rate and blood pressure of hyperactive children with special reference to time of action
Psychopharmacologia
Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents
J Autism Dev Disord
Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder
J Am Acad Child Adolesc Psychiatry
Practice parameters for the assessment and treatment of children and adolescents with depressive disorders
J Am Acad Child Adolesc Psychiatry
Practice parameters for the assessment and treatment of children and adolescents with schizophrenia
J Am Acad Child Adolesc Psychiatry
Practice parameter for the use of stimulant medications in the treatment of children, adolescents and adults
J Am Acad Child Adolesc Psychiatry
The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children
J Autism Dev Disord
Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms
Am J Psychiatry
Depression in youth: psychosocial interventions
J Clin Child Psychol
Family treatment of childhood anxiety: a controlled trial
J Consult Clin Psychol
Cited by (107)
Intervention recommendations and subsequent access to services following clinical assessment for fetal alcohol spectrum disorders
2017, Research in Developmental DisabilitiesCitation Excerpt :Pei, Job, Poth, & Atkinson, 2013). Finally, examination of the pattern of recommendations implemented, and those reported as valuable for other youth with disability (e.g. Austism, Attention Deficit Hyperactivity Disorder, mental health issues) reveal a large amount of overlap in the types of services provided and deemed effective (McCellan & Werry, 2003; Myers & Johnson, 2007; Subcommittee on Attention-Deficit, 2011). Consequently although individuals with FASD or PAE may require some specialized services, or access to more services, in general good practice is good practice.
Child-centered play therapy with young children who are anxious: A controlled trial
2015, Children and Youth Services ReviewCitation Excerpt :Due to the early onset of anxiety and the high risks associated with untreated anxiety, early-intervention programs are crucial to change the trajectory for anxious children (Pollock et al., 2006). Prior to this study, CBT had been deemed the most appropriate intervention for children with anxiety (Compton et al., 2004; McClellan & Werry, 2003; Silverman et al., 2008), despite the reported flaws and potential developmental inappropriateness for young children in addition to the high percentages of children who do not improve as a result of successfully completing treatment (McKay & Storch, 2009; Rey et al., 2011; Silverman et al., 2008). The prevalence rates of anxiety in children and the adverse effects of not intervening early further increase the importance of utilizing an intervention that meets the developmental needs of young children and can effectively improve symptoms of anxiety.
Pharmacotherapy of autism spectrum disorders
2013, Brain and DevelopmentCitation Excerpt :The use of medications in complex heterogeneous development disorder, such as ASDs, is challenging. The gold standard for evidence-based use of pharmacological agents is double blind placebo controlled clinical trials [84]. Unfortunately, the evidence for significant effects in medication studies of children with ASDs is limited by the small number of patients, the lack of consistent replications and the short duration of all the studies reported to date.
A Review on Autism Spectrum Disorder: Pathogenesis, Biomarkers, Pharmacological and Non-Pharmacological Interventions
2023, CNS and Neurological Disorders - Drug TargetsClinical excellence in child and adolescent psychiatry: examples from the published literature
2023, International Journal of Psychiatry in Clinical Practice
Drs. McClellan and Werry have compiled a snapshot of the status of our field with respect to evidence-based treatment. This is an unusual feature for the Journal, although our psychology colleagues have completed a similar task in a more comprehensive format. I would appreciate your feedback on whether you find the concept and/or the format useful in your clinical work and teaching. M.K.D.